Renfeng Guo
Fondatore presso INFLARX N.V.
Patrimonio netto: 2 M $ in data 30/04/2024
Profilo
Renfeng Guo founded InflaRx GmbH in 2007, where he worked as Chief Scientific Officer from 2009 to 2012 and InflaRx NV in 2007, where he is working as Executive Director & Chief Scientific Officer from 2007.
Dr. Guo also formerly worked at the University of Michigan, as Associate Professor.
Dr. Guo received his doctorate degree from Norman Bethune Medical University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INFLARX N.V.
2.99% | 31/12/2023 | 1 762 144 ( 2.99% ) | 2 M $ | 30/04/2024 |
Posizioni attive di Renfeng Guo
| Società | Posizione | Inizio |
|---|---|---|
| INFLARX N.V. | Fondatore | 01/12/2007 |
Precedenti posizioni note di Renfeng Guo
| Società | Posizione | Fine |
|---|---|---|
| University of Michigan | Corporate Officer/Principal | - |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Fondatore | - |
Formazione di Renfeng Guo
| Norman Bethune Medical University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INFLARX N.V. | Health Technology |
| Aziende private | 1 |
|---|---|
InflaRx GmbH
InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Health Technology |
- Borsa valori
- Insiders
- Renfeng Guo
